Approved therapies dominate the obsessive-compulsive disorder drugs market. However, the heterogeneous nature of both OCD disorder and patients’ response to treatment has increased the use of off-label drugs in combination with the approved ones. Across the world, many obsessive-compulsive disorder treatment guidelines include the use of off-label therapies as the second-line treatment due to relapse and refractory to first-line medication. These factors are increasing the use of off-label therapies, which will bolster the sales volume for the vendors of the global obsessive-compulsive disorder drugs market over the forecast period.
Seattle, WA -- (SBWIRE) -- 11/26/2019 -- Global Obsessive-Compulsive Disorder Drugs Market Overview
The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D of new drugs with improved bioavailability, pharmacology, safety, and dosage parameters. These new OCD drugs are currently being evaluated and will enroll soon by a series of new launches. As a result, the demand for these drugs will increase.
For More Info and for a Sample Copy: https://www.worldwidemarketreports.com/sample/135175
Top Obsessive-Compulsive Disorder Drugs Companies Covered in this Market Research Report
The obsessive-compulsive disorder drugs market is fragmented. This report provides an analysis of the market's competitive landscape and offers information on the products offered by various companies. The review will help clients in improving their market positions. It also provides a detailed analysis of the upcoming obsessive-compulsive disorder drugs market trends and challenges and how they influence its growth. The research will help companies in creating effective strategies to leverage the upcoming market growth opportunities.
The SSRI segment dominated the obsessive-compulsive disorder drugs market in 2018. This was primarily because of the presence of a large number of SSRI such as fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, and escitalopram in the market. SSRI has fewer side effects compared with TCA and other classes of drugs, hence considered as first-line of treatment for OCD. They can also be used as monotherapy or in combination with other drugs. Because of these benefits, many generic versions of these drugs have been approved in the US, Japan, and the European Union. Furthermore, many new companies are developing controlled release and sustained release formulations of SSRI. These factors will drive the growth of this market segment over the forecast period.
The report offers a detailed analysis of a few leading Obsessive-Compulsive Disorder Drugs companies, including the following: AbbVie Inc., Addex Therapeutics Ltd, C4X Discovery Limited, F. Hoffmann-La Roche Ltd., Novartis AG, Omeros Corporation, Rottapharm SpA, Sellas Inc.
The growing incidence of obsessive-compulsive disorder and rising government initiatives to combat the health condition, and availability of OCD drugs have been the primary market growth drivers in North America. The region held the highest market share in 2018. Additionally, the obsessive-compulsive disorder drugs market in North America is expected to record several drug development and launches in the coming years for the treatment of OCD. As a result, it will maintain its market dominance until 2027.
Key Highlights of the Global Obsessive-Compulsive Disorder Drugs Market Forecast Report for the Period 2019-2027
- CAGR of the market during the forecast period 2019-2027
- Detailed information on factors that will accelerate the growth of the obsessive-compulsive disorder drugs market during the next five years
- Precise estimation of the global obsessive-compulsive disorder drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the obsessive-compulsive disorder drugs industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market's competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of obsessive-compulsive disorder drugs companies
Place an Enquiry For Complete List of Key Players: https://www.worldwidemarketreports.com/quiry/135175